Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Fidelity MSCI Health Care Index ETF (FHLC) is a passively managed exchange traded fund launched on October 21, 2013.
If You Hold This Healthcare ETF, You're Losing Big
The Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) is down about 5% year to date while the S&P 500 is up 7%.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Launched on October 21, 2013, the Fidelity MSCI Health Care Index ETF (FHLC) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) Short Interest Up 126.7% in February
Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC - Get Free Report) was the target of a significant increase in short interest in February. As of February 27th, there was short interest totaling 100,535 shares, an increase of 126.7% from the February 12th total of 44,344 shares. Based on an average daily trading volume, of 144,995
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Launched on October 21, 2013, the Fidelity MSCI Health Care Index ETF (FHLC) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
Is Fidelity's Health Care ETF A Good Buy Right Now?
Healthcare investing offers defensive characteristics during market turbulence, yet regulatory uncertainty and political risk can trigger sudden selloffs.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
The Fidelity MSCI Health Care Index ETF (FHLC) was launched on October 21, 2013, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
FHLC: Why Patience Matters More Than Precision
Fidelity MSCI Health Care Index ETF offers long-term growth potential, leveraging demographic tailwinds and biotech innovation, but requires patience through cycles. FHLC's market-cap weighting enables dynamic exposure, reducing biotech risk in downturns and capturing upside in rallies, outperforming pure biotech or pharma over a decade. Currently, FHLC is highly concentrated in pharma, with Eli Lilly and Company at ~13%, which enhances near-term resilience but increases drawdown risk if heavyweights underperform.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the Fidelity MSCI Health Care Index ETF (FHLC), a passively managed exchange traded fund launched on October 21, 2013.
Midyear Sector Roundup: AI Enthusiasm Drives Returns
Midyear can be an ideal opportunity for investors to re-evaluate their portfolios and consider rebalancing to align with their ideal asset allocation. As the midpoint of 2025 passes, the U.S. stock market has delivered a mixed bag of performance across sectors, driven largely by continued enthusiasm for artificial intelligence (AI) and fluctuating economic conditions.
FHLC: An Average Healthcare ETF
FHLC is a solid healthcare ETF, but VHT offers slightly better performance, liquidity, and diversification for a similar expense ratio. FHLC's high concentration in top holdings and lower trading volume raise concerns compared to VHT's broader portfolio and superior liquidity. Healthcare sector tailwinds like innovation, aging demographics, and biotech growth benefit all major ETFs, but VHT stands out on key metrics.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
The Fidelity MSCI Health Care Index ETF (FHLC) was launched on 10/21/2013, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
